Daphne L. Taylor
VP, Chief Accounting Officer, Cardiac Science CORP.
Companies
- Aptevo Therapeutics Inc.Chief financial officer Mar 7, 2023 to now1
- BIOLIFE SOLUTIONS INCChief financial officer Aug 23, 2011 to May 6, 20152
Holdings
Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.
Shares held
- Aptevo Therapeutics Inc. APVO638 shares3$1.0K at $1.61Aug 6, 2026
As of each latest filing. The line shows shares held over time.
Recent filings
- Aug 6, 2026Exercised options 638 shares of Aptevo Therapeutics Inc.3
- Jul 17, 2025Exercised options 3 shares of Aptevo Therapeutics Inc.4
- Mar 4, 2025Exercised options 1 shares of Aptevo Therapeutics Inc.5
- Mar 2, 2025Exercised options 2 shares of Aptevo Therapeutics Inc.5
- Aug 8, 2024Exercised options 158 shares of Aptevo Therapeutics Inc.6
- Mar 4, 2024Exercised options 1,584 shares of Aptevo Therapeutics Inc.7
- Mar 2, 2024Exercised options 3,667 shares of Aptevo Therapeutics Inc.7
- Jan 29, 2024Exercised options 792 shares of Aptevo Therapeutics Inc.8
- Aug 8, 2023Exercised options 6,945 shares of Aptevo Therapeutics Inc.9
- Mar 4, 2023Exercised options 1,583 shares of Aptevo Therapeutics Inc.10
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4SEC EDGARForm 4 filed Jul 21, 2025
- 5SEC EDGARForm 4 filed Mar 4, 2025
- 6SEC EDGARForm 4 filed Aug 9, 2024
- 7SEC EDGARForm 4 filed Mar 5, 2024
- 8SEC EDGARForm 4 filed Jan 30, 2024
- 9SEC EDGARForm 4 filed Aug 10, 2023
- 10SEC EDGARForm 4 filed Mar 7, 2023